tiprankstipranks
Trending News
More News >
Serina Therapeutics, Inc. (SER)
:SER
US Market
Advertisement

Serina Therapeutics (SER) Income Statement

Compare
196 Followers

Serina Therapeutics Income Statement

Last quarter (Q1 2025), Serina Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Serina Therapeutics's net income was $-4.81M. See Serina Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 56.00K$ 3.15M$ 500.00K$ 3.04M$ 54.00K
Gross Profit
$ -138.00K$ -29.00K$ 355.00K$ 2.89M$ -1.23M
Operating Expenses
$ 16.91M$ 6.13M$ 2.77M$ 8.03M$ 9.18M
Depreciation and Amortization
$ 194.00K$ 131.00K$ 132.00K$ 33.37K$ 1.25M
EBITDA
$ -10.49M$ 5.92M$ -2.60M$ -7.35M$ -8.74M
Operating Income
$ -17.05M$ -3.13M$ -2.27M$ -1.63M$ -10.41M
Other Income/Expenses
$ 5.84M$ 8.40M$ -411.74K$ 366.81K$ 8.00K
Pretax Income
$ -11.21M$ 5.27M$ -2.68M$ -8.58M$ -10.40M
Net Income
$ -11.14M$ 5.27M$ -2.68M$ -8.68M$ -10.87M
Per Share Metrics
Basic EPS
$ -1.51$ 0.63$ -2.49$ -1.17$ -10.14
Diluted EPS
$ -1.51$ 0.63$ -2.49$ -1.17$ -10.14
Weighted Average Shares Outstanding
7.36M 8.41M 1.08M 1.08M 1.07M
Weighted Average Shares Outstanding (Diluted)
7.36M 8.41M 1.08M 1.08M 1.07M
Currency in USD

Serina Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis